Devices › Device types
FDA product code DXC · class 2 · Cardiovascular
Clamp, vascular: medical device reports filed with FDA
13,077 reports carry this product code, 1994–2026; 27 brands with a page.
- 13,077
- reports with this product code
- 0.1% of all MAUDE reports
- 811
- reports, 12 months to August 2026
- 444 in the 12 months before
- 88%
- classified as malfunction
- 62.3% across all reports
- 0.6%
- classified as death, as reported
- 0.9% across all reports
Product code DXC is FDA's classification for "Clamp, vascular" (cardiovascular panel), a class 2 device. 13,077 medical device reports carry this product code, 0.1% of the MAUDE database, from February 1994 to August 2026.
811 reports arrived in the 12 months to August 2026, up 83% from 444 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88%), injury (10.7%) and death (0.6%). 27 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Guidant 4 5 Mm Heartstring Proximal Seal | 2,617 | 0 | 0% | 92.1% |
| Tr Band | 1,269 | 571 | 0.2% | 82.8% |
| Guidant 4 5mm Heartstring Proximal Seal | 615 | 0 | 0% | 90.4% |
| Tr Band Radial Compression Device | 292 | 1 | 0% | 69.9% |
| Endoclamp Aortic Catheter | 99 | 0 | 2.4% | 72.8% |
| Acrobat-i Stabilizer | 56 | 37 | 0.2% | 98.3% |
| VasoView Hemopro 2 | 28 | 686 | 0% | 92.6% |
| Vaso View Hemopro | 17 | 0 | 0.1% | 86.7% |
| Resolution Clip Device | 12 | 0 | 0.3% | 90.3% |
| Vasoview 6 Pro | 7 | 8 | 0% | 94.5% |
| Vasoview 7 Xb | 7 | 0 | 0% | 90.2% |
| HemoPro2 Extension Cable | 4 | 30 | 0% | 98.5% |
| Karl Storz | 4 | 0 | 2.1% | 24.6% |
| Vasoview Hemopro 2 Evh System | 4 | 0 | 0% | 82.6% |
| Hemopro2 Adaptor | 3 | 14 | 0% | 97% |
| Vasoview Hemopro 2 With Vasoshield | 3 | 0 | 0% | 90.9% |
| Asku | 2 | 210 | 1.1% | 47.1% |
| Guidant Vasoview 5 Harvesting Cannula | 2 | 0 | 0.3% | 87.2% |
| Ni | 2 | 1,587 | 1.8% | 29.5% |
| Starclose Vascular Closure System | 2 | 8 | 1.2% | 46% |
| Vasoview Hemopro | 2 | 0 | 0% | 85.3% |
| Bom 7mm Extended Length Endoscope | 1 | 0 | 0% | 97.6% |
| Dc Extension Cable | 1 | 0 | 0% | 98.9% |
| Perclose ProGlide | 1 | 653 | 0.9% | 16.1% |
| Resolution Clip | 1 | 36 | 0.1% | 98.3% |
| S5 Gas Blender System | 1 | 0 | 0% | 90.6% |
| Vasoviewhempro Vh-3500 | 1 | 0 | 0% | 86.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Maquet Cardiovascular | 5,164 | 39.5% |
| Guidant Cardiac Surgery | 3,484 | 26.6% |
| Terumo Medical | 1,263 | 9.7% |
| Maquet Cv | 948 | 7.2% |
| Edwards Lifesciences | 275 | 2.1% |
| Terumo Ashitaka | 177 | 1.4% |
| Applied Medical Resources | 154 | 1.2% |
| Livanova Deutschland | 148 | 1.1% |
| Synovis Surgical Innovations | 87 | 0.7% |
| Edwards Lifesciences Pr | 83 | 0.6% |
| Ethicon | 38 | 0.3% |
| Merit Medical Systems | 23 | 0.2% |
| St Jude Medical | 18 | 0.1% |
| Applied Medical | 15 | 0.1% |
| St Jude Medical Puerto Rico | 12 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Replace | 2,473 | 18.9% |
| Crackthe device cracked | 2,292 | 17.5% |
| Positioning failure | 1,793 | 13.7% |
| Fitting problem | 1,413 | 10.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 1,078 | 8.2% |
| Gas/air leak | 760 | 5.8% |
| Unraveled material | 443 | 3.4% |
| Activation problem | 424 | 3.2% |
| Sticking | 376 | 2.9% |
| Unintended deflation | 371 | 2.8% |
| Deflation problem | 359 | 2.7% |
| Breakthe device broke | 307 | 2.3% |
| Failure to advance | 281 | 2.1% |
| Device difficult to setup or prepare | 274 | 2.1% |
| Failure to unfold or unwrap | 221 | 1.7% |
| Difficult to removethe device was hard to remove | 211 | 1.6% |
| Activation, positioning or separation problem | 189 | 1.4% |
| Detachment of device component | 164 | 1.3% |
| Air leak | 156 | 1.2% |
| Difficult to open or close | 147 | 1.1% |
Questions about clamp, vascular reports
What is product code DXC?
FDA's classification code for "Clamp, vascular", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
13,077 reports through August 2026, 811 of them in the latest 12 months.
Which brands appear most often?
Guidant 4 5 Mm Heartstring Proximal Seal (2,617), Tr Band (1,269), Guidant 4 5mm Heartstring Proximal Seal (615), Tr Band Radial Compression Device (292) and Endoclamp Aortic Catheter (99). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.